Skip to content

NBIX

Neurocrine Biosciences, Inc.

NASDAQ · USHealthcareDrug Manufacturers - Specialty & Generic
$173.00+1.24%

Price as of Jul 20, 2026

NBIX analysis

Neurocrine Biosciences, Inc. stock analysis

Published Drillr research and company-specific analysis. Existing articles keep their current URLs and citation behavior.

Analysis for NBIX is not published yet

Browse the public research library while company-specific analysis is being prepared. Explore research